Mortality audit of COVID-19 infection among children

Raman Sharma1, Ashish Agarwal1, Ankit Ranjan2

  • 1Division of Paediatric Emergency & Critical Care, Advanced Paediatrics Centre, Postgraduate Institute of Medical Education & Research, Chandigarh, India.

Insights

In children with SARS-CoV-2 infection, all-cause mortality was 9.9%, while COVID-19 specific mortality was 1.9%. Most deaths were linked to underlying comorbidities, not solely the virus.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Critical Care Medicine

Background:

  • Severe COVID-19 is uncommon in children, leading to limited data on mortality causes.
  • Understanding mortality in pediatric SARS-CoV-2 infections is crucial for accurate risk assessment.

Purpose of the Study:

  • To determine all-cause mortality and COVID-19 specific mortality in children admitted to a pediatric COVID facility.
  • To identify the causes of death in non-survivor children infected with SARS-CoV-2.

Main Methods:

  • Retrospective analysis of clinical and epidemiological data of SARS-CoV-2 positive children (0-12 years).
  • Study conducted at a tertiary care COVID hospital in North India from April 2020 to June 2021.
  • Focused on non-survivors to determine causes of death.

Main Results:

  • 475 children admitted, 47 died (9.9% all-cause mortality).
  • COVID-19 specific mortality was 1.9% (9 deaths).
  • Comorbidities (prematurity, congenital heart disease) were present in 74.5%; common causes of death included septic shock, COVID pneumonia, and neonatal illnesses.

Conclusions:

  • A low disease-specific mortality from COVID-19 was observed in children.
  • Mortality in pediatric COVID-19 cases can be overestimated if all-cause and disease-specific deaths are not differentiated.
  • Standardized recording of causes of death in pediatric SARS-CoV-2 infections is essential.
Abstract

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
117
Life Tables01:22

Life Tables

A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
167
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
428
Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
203
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
392